Haemophilia trials in Denmark

In Denmark 11 Also abroad 131

11 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Where
Copenhagen Oe
Age
12 years and over
People
360 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07416604 · EU 2025-522435-33-00
Phase 3Taking people
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Where
Aarhus N
Age
18 years and over
People
84 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07830732 · EU 2026-525529-19-00
Phase 3Taking people
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Where
Aarhus N, Copenhagen Oe
Age
1 year to 74 years
People
245 worldwide
Run by
Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00
No phaseTaking people
An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
Where
Many Locations
Age
7 years to 12 years
People
40 worldwide
Run by
Bayer
See details and how to joinNCT07088458
Phase 3Taking people
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Where
Copenhagen Oe
Age
12 years and over
People
138 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07416526 · EU 2025-522434-32-00
Phase 3Taking people
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Where
Aarhus N, Copenhagen Oe
Age
1 year to 17 years
People
100 worldwide
Run by
Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00
No phaseEnrolling by invitation
Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol
Where
Søborg
People
50
Run by
Novo Nordisk A/S
See details and how to joinNCT04682145
No phaseEnrolling by invitation
A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
Where
Aarhus N
People
60 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT03745924
No phaseTaking people
An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
Where
Århus N
Age
18 years and over
People
500 worldwide
Run by
CSL Behring
See details and how to joinNCT06008938
No phaseTaking people
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Where
Aarhus
People
4,000 worldwide
Run by
PedNet Haemophilia Research Foundation
See details and how to joinNCT02979119
Phase 2/3Enrolling by invitation
Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)
Where
Copenhagen Oe
Age
18 years and over
People
56 worldwide
Run by
CSL Behring
See details and how to joinNCT05962398 · EU 2023-503765-37-00